- Investing Ideas
- /
- Hong Kong Pharmaceuticals & Biotech Solid Balance Sheet and Fundamentals
Hong Kong Pharmaceuticals & Biotech Solid Balance Sheet and Fundamentals
Results
2
0 new
High return on equity, past performance and sound balance sheet.
2 companies
Consun Pharmaceutical Group
Market Cap: HK$13.2b
Researches and develops, manufactures, and sells Chinese medicines and medical contrast medium products in the People’s Republic of China.
1681
HK$15.98
7D
-1.1%
1Y
173.6%
HBM Holdings
Market Cap: HK$13.7b
A biopharmaceutical company, engages in the discovery, development, and commercialization of antibody therapeutics focusing on immunology and oncology in Mainland China, the United States, Europe, and internationally.
2142
HK$16.38
7D
-4.4%
1Y
1,349.6%